Treatment with rituximab and brentuximab vedotin in a patient of common variable immune deficiency-associated classic Hodgkin lymphoma
about
Treatment with rituximab and brentuximab vedotin in a patient of common variable immune deficiency-associated classic Hodgkin lymphoma
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Treatment with rituximab and b ...... iated classic Hodgkin lymphoma
@ast
Treatment with rituximab and b ...... iated classic Hodgkin lymphoma
@en
type
label
Treatment with rituximab and b ...... iated classic Hodgkin lymphoma
@ast
Treatment with rituximab and b ...... iated classic Hodgkin lymphoma
@en
prefLabel
Treatment with rituximab and b ...... iated classic Hodgkin lymphoma
@ast
Treatment with rituximab and b ...... iated classic Hodgkin lymphoma
@en
P2093
P2860
P1433
P1476
Treatment with rituximab and b ...... iated classic Hodgkin lymphoma
@en
P2093
Efren Rael
Hong Zheng
Kevin Rakszawski
Kristian Koller
Manish Butte
Michael Bayerl
P2860
P2888
P356
10.1186/S40364-016-0061-8
P577
2016-03-09T00:00:00Z
P5875
P6179
1035267739